Related Experiment Videos
Rett syndrome: clinical and molecular update
1Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA. apercy@uab.edu
Current Opinion in Pediatrics
|November 19, 2004
Summary
Recent advances in Rett syndrome offer new insights into clinical management and genetic discoveries related to the methyl-CpG-binding protein 2 gene (MECP2). Understanding MECP2 mutations improves knowledge of this disorder and broader neurobiology.
Area of Science:
- Neuroscience
- Genetics
- Pediatrics
Background:
- Rett syndrome is a rare neurodevelopmental disorder.
- Mutations in the methyl-CpG-binding protein 2 gene (MECP2) are the primary cause.
- Recent research has accelerated understanding of its clinical and molecular aspects.
Purpose of the Study:
- To review recent advances in Rett syndrome.
- To cover clinical management and genetic discoveries.
- To explore implications for neurobiology beyond Rett syndrome.
Main Methods:
- Literature review of recent publications.
- Analysis of clinical data and genetic findings.
- Examination of animal models and human studies of MECP2.
Main Results:
- Clinical management strategies address electrocardiographic findings, scoliosis, osteopenia, and motor control.
- Phenotype-genotype correlations are emerging, particularly with large-scale MECP2 deletions and alternate splicing isoforms.
- Animal models have significantly elucidated the neurobiologic role of MECP2.
Conclusions:
- Advances in understanding MECP2 mutations provide a clearer picture of the Rett syndrome spectrum.
- Research on MECP2 is crucial for both Rett syndrome and normal neurodevelopment.
- Continued investigation holds promise for improved clinical management and therapeutic strategies.